BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20047735)

  • 1. Energy minimum theorem based on AGA, Lyapunov and force field for CADD techniques.
    Sung WT; Liu YF
    Comput Biol Med; 2010 Feb; 40(2):215-22. PubMed ID: 20047735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semiempirical free energy force field with charge-based desolvation.
    Huey R; Morris GM; Olson AJ; Goodsell DS
    J Comput Chem; 2007 Apr; 28(6):1145-52. PubMed ID: 17274016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
    Daeyaert F; de Jonge M; Heeres J; Koymans L; Lewi P; Vinkers MH; Janssen PA
    Proteins; 2004 Feb; 54(3):526-33. PubMed ID: 14748000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
    Klon AE; Glick M; Davies JW
    J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.
    Fujimoto T; Matsushita Y; Gouda H; Yamaotsu N; Hirono S
    Bioorg Med Chem Lett; 2008 May; 18(9):2771-5. PubMed ID: 18434150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
    Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate prediction for atomic-level protein design and its application in diversifying the near-optimal sequence space.
    Fromer M; Yanover C
    Proteins; 2009 May; 75(3):682-705. PubMed ID: 19003998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated molecular simulation based binding affinity calculator for ligand-bound HIV-1 proteases.
    Sadiq SK; Wright D; Watson SJ; Zasada SJ; Stoica I; Coveney PV
    J Chem Inf Model; 2008 Sep; 48(9):1909-19. PubMed ID: 18710212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated docking and the search for HIV protease inhibitors.
    Olson AJ; Goodsell DS
    SAR QSAR Environ Res; 1998; 8(3-4):273-85. PubMed ID: 9522477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based ligand design by dynamically assembling molecular building blocks at binding site.
    Liu H; Duan Z; Luo Q; Shi Y
    Proteins; 1999 Sep; 36(4):462-70. PubMed ID: 10450088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
    Alcaro S; Artese A; Ceccherini-Silberstein F; Ortuso F; Perno CF; Sing T; Svicher V
    J Chem Inf Model; 2009 Jul; 49(7):1751-61. PubMed ID: 19537723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a MIP-based alignment and docking in computer-aided drug design.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
    Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm.
    Wu G; Robertson DH; Brooks CL; Vieth M
    J Comput Chem; 2003 Oct; 24(13):1549-62. PubMed ID: 12925999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking to ensembles of protein structures.
    Knegtel RM; Kuntz ID; Oshiro CM
    J Mol Biol; 1997 Feb; 266(2):424-40. PubMed ID: 9047373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of new HIV inhibitors based on the database of traditional Chinese medicine].
    Gao WN; Li Y; Zhang R; Gao H; Xu WR; Li AX; Du QS; Zhang X; Wei DQ
    Yao Xue Xue Bao; 2006 Mar; 41(3):241-6. PubMed ID: 16758996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.